chr10-110823536-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001134363.3(RBM20):​c.3373G>A​(p.Glu1125Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00376 in 1,545,238 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0038 ( 20 hom. )

Consequence

RBM20
NM_001134363.3 missense

Scores

5
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 3.33
Variant links:
Genes affected
RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007486701).
BP6
Variant 10-110823536-G-A is Benign according to our data. Variant chr10-110823536-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 44009.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-110823536-G-A is described in Lovd as [Benign]. Variant chr10-110823536-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00326 (484/148400) while in subpopulation NFE AF= 0.00457 (309/67630). AF 95% confidence interval is 0.00415. There are 0 homozygotes in gnomad4. There are 227 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 484 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RBM20NM_001134363.3 linkuse as main transcriptc.3373G>A p.Glu1125Lys missense_variant 12/14 ENST00000369519.4 NP_001127835.2
RBM20XM_017016103.3 linkuse as main transcriptc.3208G>A p.Glu1070Lys missense_variant 12/14 XP_016871592.1
RBM20XM_017016104.3 linkuse as main transcriptc.2989G>A p.Glu997Lys missense_variant 12/14 XP_016871593.1
RBM20XM_047425116.1 linkuse as main transcriptc.2989G>A p.Glu997Lys missense_variant 12/14 XP_047281072.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RBM20ENST00000369519.4 linkuse as main transcriptc.3373G>A p.Glu1125Lys missense_variant 12/141 NM_001134363.3 ENSP00000358532 P1

Frequencies

GnomAD3 genomes
AF:
0.00326
AC:
484
AN:
148290
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000782
Gnomad AMI
AF:
0.00664
Gnomad AMR
AF:
0.00376
Gnomad ASJ
AF:
0.0180
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000426
Gnomad FIN
AF:
0.00121
Gnomad MID
AF:
0.00327
Gnomad NFE
AF:
0.00457
Gnomad OTH
AF:
0.00295
GnomAD3 exomes
AF:
0.00362
AC:
567
AN:
156520
Hom.:
4
AF XY:
0.00354
AC XY:
294
AN XY:
82962
show subpopulations
Gnomad AFR exome
AF:
0.000379
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.0187
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000483
Gnomad FIN exome
AF:
0.00166
Gnomad NFE exome
AF:
0.00509
Gnomad OTH exome
AF:
0.00296
GnomAD4 exome
AF:
0.00381
AC:
5325
AN:
1396838
Hom.:
20
Cov.:
35
AF XY:
0.00382
AC XY:
2630
AN XY:
688914
show subpopulations
Gnomad4 AFR exome
AF:
0.000606
Gnomad4 AMR exome
AF:
0.00202
Gnomad4 ASJ exome
AF:
0.0179
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00105
Gnomad4 FIN exome
AF:
0.00167
Gnomad4 NFE exome
AF:
0.00403
Gnomad4 OTH exome
AF:
0.00429
GnomAD4 genome
AF:
0.00326
AC:
484
AN:
148400
Hom.:
0
Cov.:
30
AF XY:
0.00314
AC XY:
227
AN XY:
72256
show subpopulations
Gnomad4 AFR
AF:
0.000780
Gnomad4 AMR
AF:
0.00375
Gnomad4 ASJ
AF:
0.0180
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000426
Gnomad4 FIN
AF:
0.00121
Gnomad4 NFE
AF:
0.00457
Gnomad4 OTH
AF:
0.00292
Alfa
AF:
0.00493
Hom.:
0
Bravo
AF:
0.00323
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00534
AC:
17
ExAC
AF:
0.00340
AC:
81
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 10, 2017p.Glu1125Lys in exon 12 of RBM20: This variant is classified as benign because i t has been identified in 1.8% (157/8538) of Ashkenazi Jewish chromosomes, includ ing 4 homozygotes by the Genome Aggregation Database (gnomAD, http://gmomad.broa dinstitute.org; dbSNP rs116908219). -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 30, 2020Variant summary: RBM20 c.3373G>A (p.Glu1125Lys) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0036 in 156520 control chromosomes in the gnomAD database, including 4 homozygotes. The observed variant frequency is approximately 145-fold the estimated maximal expected allele frequency for a pathogenic variant in RBM20 causing Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is benign. c.3373G>A has been reported in the literature in individuals affected with Cardiomyopathy without strong evidence for causality (examples- Lopes_2013, Pugh_2014, Bottillo_2016, Jaaskelainen_2019). These reports do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Nine clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. They have cited the variant as benign (n=4), likely benign (n=4) and uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingGeneDxJan 10, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteMay 18, 2016- -
Dilated cardiomyopathy 1DD Benign:4
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024RBM20: BP4, BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioAug 18, 2017- -
Long QT syndrome;C0349788:Arrhythmogenic right ventricular cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Advanced Laboratory Medicine, UC San Diego Health, University of California San DiegoMar 18, 2019- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 25, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.070
CADD
Benign
22
DANN
Uncertain
1.0
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Benign
0.54
D
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0075
T
MetaSVM
Benign
-0.50
T
MutationTaster
Benign
0.99
D
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.8
N
REVEL
Uncertain
0.32
Sift
Benign
0.037
D
Sift4G
Benign
0.073
T
Vest4
0.29
MVP
0.71
ClinPred
0.011
T
GERP RS
6.2
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116908219; hg19: chr10-112583294; API